4.814EUR-2.43%Mkt Cap: 94.21M EURP/E: —Last update: 2026-06-01
Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic pr…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap94.21M EUR
Enterprise Value—
Revenue (TTM)3.85M EUR
Gross Profit683.00K EUR
Net Income (TTM)-16.59M EUR
Revenue/Share—
Last Price4.814 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-12.26
PEG—
EV/EBITDA—
EV/Revenue—
P/S25.09
P/B-145.12
EPS (TTM)-0.90
EPS (Forward)-0.40
52W Range
3.40016% of range12.40
52W High12.40 EUR
52W Low3.400 EUR
Profitability
Gross Margin46.31%
Oper. Margin-414.25%
EBITDA Margin0.00%
Profit Margin-1124.81%
ROE-1112.74%
ROA-58.31%
Growth
Revenue Growth-84.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.53M EUR
CapEx (TTM)267.00K EUR
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity5.97
Current Ratio—
Quick Ratio—
Book Value/Sh-0.0340 EUR
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)13.00 EUR
Target Range11.00 EUR – 16.00 EUR
# Analysts3
Ownership
Shares Out.19.57M
Float—
Insiders9.93%
Institutions8.18%
Technical
SMA 504.837 (-0.5%)
SMA 2006.833 (-29.6%)
Beta0.27
S&P 52W Chg27.94%
Avg Vol (30d)262.93K
Avg Vol (10d)178.16K
Technical Indicators
RSI (14)50.1
MACD-0.0029
MACD Signal-0.0186
MACD Hist.+0.0158
BB Upper5.139 EUR
BB Middle4.901 EUR
BB Lower4.663 EUR
BB Width9.70%
ATR (14)0.2875 EUR
Vol Ratio (20d)0.82x